• OPEN AN ACCOUNT
Indian Indices
Sensex
81,666.46 943.52
( 1.17%)
Global Indices
Nasdaq
48,928.31 -164.26
(-0.33%)
Dow Jones
6,963.16 -26.85
(-0.38%)
Hang Seng
52,813.31 -509.54
(-0.96%)
Nikkei 225
10,214.90 43.14
(0.42%)
Forex
USD-INR
91.66 -0.27
(-0.29%)
EUR-INR
108.61 -1.36
(-1.24%)
GBP-INR
125.41 -1.53
(-1.21%)
JPY-INR
0.59 -0.01
(-1.35%)

EQUITY - MARKET SCREENER

Venus Remedies Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
526953
INE411B01019
467.2458657
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
VENUSREM
15.73
1111.4
EPS(TTM)
Face Value()
Div & Yield %
52.85
10
0
 

star housing finance ltd
Tata Motors Passenger Vehicles update on composite scheme of arrangement
Jan 08,2026
Tata Motors Passenger Vehicles announced that TP Paarthav (TPPL) has ceased to be an associate of the company with effect from 08 January 2025.

Earlier in September 2025, the company had intimated execution of Share Subscription and Shareholders' Agreement with Tata Power Renewable Energy to acquire 26% equity stake in TPPL, a special purpose vehicle (SPV).

In terms of the actual investment in the aforesaid SPV and in terms of the Composite Scheme of Arrangement as sanctioned by the Hon'ble National Company Law Tribunal, the stake of Tata Motors Passenger Vehicles in TPPL stands reduced to 12.89%.